董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Kenneth R. Melani | 男 | Chairman of the Board | 70 | 未披露 | 未持股 | 2023-05-15 |
| Zeev Rotstein | 男 | Director | 73 | 未披露 | 未持股 | 2023-05-15 |
| Urs Wettstein | 男 | Director | 68 | 未披露 | 未持股 | 2023-05-15 |
| Yacov Geva | 男 | President and Chief Executive Officer, Director | 73 | 未披露 | 未持股 | 2023-05-15 |
| Chanan Epstein | 男 | Director | 70 | 未披露 | 未持股 | 2023-05-15 |
| Yehoshua Gleitman | 男 | Director | 74 | 未披露 | 未持股 | 2023-05-15 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Benny Tal | 男 | Vice President Research and Development Corporate | 64 | 未披露 | 未持股 | 2023-05-15 |
| Oded Shahar | 男 | Senior Vice President Mergers and Acquisitions Corporate | 63 | 未披露 | 未持股 | 2023-05-15 |
| Yacov Geva | 男 | President and Chief Executive Officer, Director | 73 | 未披露 | 未持股 | 2023-05-15 |
| Dror Nuriel Roth | 女 | Executive Vice President U.S. Operations | 48 | 未披露 | 未持股 | 2023-05-15 |
| Igor Bluvstein | 男 | Chief Financial Officer | 42 | 未披露 | 未持股 | 2023-05-15 |
董事简历
中英对照 | 中文 | 英文- Kenneth R. Melani
-
KennethR.Melani自2014年8月以来一直担任我们的董事会主席。Melani博士在美国梦百合行业拥有30多年的经验，作为供应商、供应者和保险公司提供服务。Melani博士于2016年4月创立Velocity Fund Partners LP，并自那时起担任其管理合伙人。Melani博士自2012年以来一直担任KRM Group的总裁兼主要所有者。从2013年到2014年，他曾担任LifeWatch AG（之前为Six:Life前身为Card Guard AG和Card Guard Scientific Survival Ltd.）的董事会主席。此前，他曾任职Highmark Inc.（原为Blue Cross of Western Pennsylvania）23年，在那里他曾担任多种职务，包括总裁兼首席执行官9年。他是许多公司的董事会成员，包括Edlogics（自2014年起），Omega梦百合Services（自2016年起）和Gen1Media（自2018年8月起）。此外，自2016年以来，他一直担任DermalBiomics，Perivance和Skinject的董事会主席。Melani博士拥有华盛顿和杰斐逊学院（Washington and Jefferson College）化学学士学位（优等生）和维克森林大学医学院（Wake Forest University School of Medicine）医学博士学位。Melani博士获得内科（ABIM）的董事会认证。
Kenneth R. Melani,has served on G Medical Innovations Holdings Ltd. board of directors as Chairman since August 2014. In April 2016, Dr. Melani founded Velocity Fund Partners LP and has since served as its managing partner. Dr. Melani has been the president and principal owner of KRM Group since 2012. From 2013 to 2014, he was the chairman of the board of directors of LifeWatch AG (previously, SIX: LIFE) (formerly Card Guard AG and Card Guard Scientific Survival Ltd.). Prior to that, he spent 23 years at Highmark Inc. (formerly Blue Cross of Western Pennsylvania), where he served in various capacities, including president and chief executive officer for nine years. He serves on the board of directors of EdLogics (since 2014), and since 2016, he has served as the chairman of the board of directors of DermalBiomics, Periovance, and SkinJect. Dr. Melani holds a B.A. in Chemistry from Washington and Jefferson College (summa cum laude) and an M.D. from Wake Forest University School of Medicine. Dr. Melani is board certified in internal medicine. - KennethR.Melani自2014年8月以来一直担任我们的董事会主席。Melani博士在美国梦百合行业拥有30多年的经验，作为供应商、供应者和保险公司提供服务。Melani博士于2016年4月创立Velocity Fund Partners LP，并自那时起担任其管理合伙人。Melani博士自2012年以来一直担任KRM Group的总裁兼主要所有者。从2013年到2014年，他曾担任LifeWatch AG（之前为Six:Life前身为Card Guard AG和Card Guard Scientific Survival Ltd.）的董事会主席。此前，他曾任职Highmark Inc.（原为Blue Cross of Western Pennsylvania）23年，在那里他曾担任多种职务，包括总裁兼首席执行官9年。他是许多公司的董事会成员，包括Edlogics（自2014年起），Omega梦百合Services（自2016年起）和Gen1Media（自2018年8月起）。此外，自2016年以来，他一直担任DermalBiomics，Perivance和Skinject的董事会主席。Melani博士拥有华盛顿和杰斐逊学院（Washington and Jefferson College）化学学士学位（优等生）和维克森林大学医学院（Wake Forest University School of Medicine）医学博士学位。Melani博士获得内科（ABIM）的董事会认证。
- Kenneth R. Melani,has served on G Medical Innovations Holdings Ltd. board of directors as Chairman since August 2014. In April 2016, Dr. Melani founded Velocity Fund Partners LP and has since served as its managing partner. Dr. Melani has been the president and principal owner of KRM Group since 2012. From 2013 to 2014, he was the chairman of the board of directors of LifeWatch AG (previously, SIX: LIFE) (formerly Card Guard AG and Card Guard Scientific Survival Ltd.). Prior to that, he spent 23 years at Highmark Inc. (formerly Blue Cross of Western Pennsylvania), where he served in various capacities, including president and chief executive officer for nine years. He serves on the board of directors of EdLogics (since 2014), and since 2016, he has served as the chairman of the board of directors of DermalBiomics, Periovance, and SkinJect. Dr. Melani holds a B.A. in Chemistry from Washington and Jefferson College (summa cum laude) and an M.D. from Wake Forest University School of Medicine. Dr. Melani is board certified in internal medicine.
- Zeev Rotstein
-
Zeev Rotstein自2019年3月以来一直担任我们的董事会成员。Rotstein教授自2016年2月起担任Hadassah Medical Organization的总干事，并担任耶路撒冷希伯来大学和特拉维夫大学萨克勒医学院的临床副教授。Rostein教授曾担任专家顾问，在世界各地建造若干医疗设施，包括赤道几内亚的Centro Medico La Paz大型转诊医院、加纳阿克拉的泻湖医院以及目前斯科尔科沃的莫斯科医疗集群肿瘤中心和综合诊所。Rotstein教授在其广泛的职业生涯中，曾担任国家医师组织的财务主管，以色列医学协会I.M.A.的世界奖学金主席，以及法国以色列人协会的编辑委员会成员。Rotstein教授曾担任I.M.A.科学委员会委员。Rotstein教授在特拉维夫大学萨克勒医学院获得心脏病学博士学位，在特拉维夫大学Leon Recanati工商管理研究生院获得工商管理硕士学位（优等生），并在塔夫茨大学纽约卫生部获得研究金，以及Johns Hopkins Medical Centre School of Health and Public Health。
Zeev Rotstein,has served on G Medical Innovations Holdings Ltd. board of directors since March 2019. Prof. Rotstein had served as the director general of Hadassah Medical Organization between February 2016 and August 2021, and as an Associate Clinical Professor at the Hebrew University of Jerusalem and, prior to this appointment, he was the Sackler School director general of Medicine Chaim Sheba Medical Center at Tel Hashomer and was an Associate Clinical Professor at Tel Aviv University. Prof. Rotstein holds the degree of Doctor of Science, Honoris Causa from the University of Nicosia and is an Honorary Fellow of the Interdisciplinary Center, Herzliya. Prof. Rotstein has acted as an expert consultant in the construction of several medical facilities throughout the world including Centro Medico La Paz, Equatorial Guinea (major referral hospital in Equatorial Guinea), the Lagoon Hospital, Accra, Ghana and currently the Hadassah Skolkovo, Moscow (a branch of Hadassah Medical Cluster Oncological Centre and Polyclinic of Skolkovo, Moscow Organization). During his extensive career, Prof. Rotstein served as treasurer at the State's Physician Organization, chairman of the World Fellowship of the Israel Medical Association (I.M.A.), and member of the Editorial Board of Associations des Médécins Israelites de France. Prof. Rotstein served as a committee member of the I.M.A. Scientific Committee. Most recently Prof. Rotstein served as Chairman of Israel's Drug Basket Committee for 2020, one of the most important positions in the Israeli health system. Prof Rotstein is also a board member in NETO-MELINDA, a public company in Tel Aviv Stock Exchange. Prof. Rotstein holds a Phan M.D. in Cardiology from the Sackler School of Medicine at the Tel- Aviv University, and an M.B.A. (cum laude) from the Leon Recanati Graduate School of Business Administration at the Tel- Aviv University, and has held fellowships at the New York Department of Health, Tufts University, and Johns Hopkins Medical Centre School of Hygiene and Public Health. - Zeev Rotstein自2019年3月以来一直担任我们的董事会成员。Rotstein教授自2016年2月起担任Hadassah Medical Organization的总干事，并担任耶路撒冷希伯来大学和特拉维夫大学萨克勒医学院的临床副教授。Rostein教授曾担任专家顾问，在世界各地建造若干医疗设施，包括赤道几内亚的Centro Medico La Paz大型转诊医院、加纳阿克拉的泻湖医院以及目前斯科尔科沃的莫斯科医疗集群肿瘤中心和综合诊所。Rotstein教授在其广泛的职业生涯中，曾担任国家医师组织的财务主管，以色列医学协会I.M.A.的世界奖学金主席，以及法国以色列人协会的编辑委员会成员。Rotstein教授曾担任I.M.A.科学委员会委员。Rotstein教授在特拉维夫大学萨克勒医学院获得心脏病学博士学位，在特拉维夫大学Leon Recanati工商管理研究生院获得工商管理硕士学位（优等生），并在塔夫茨大学纽约卫生部获得研究金，以及Johns Hopkins Medical Centre School of Health and Public Health。
- Zeev Rotstein,has served on G Medical Innovations Holdings Ltd. board of directors since March 2019. Prof. Rotstein had served as the director general of Hadassah Medical Organization between February 2016 and August 2021, and as an Associate Clinical Professor at the Hebrew University of Jerusalem and, prior to this appointment, he was the Sackler School director general of Medicine Chaim Sheba Medical Center at Tel Hashomer and was an Associate Clinical Professor at Tel Aviv University. Prof. Rotstein holds the degree of Doctor of Science, Honoris Causa from the University of Nicosia and is an Honorary Fellow of the Interdisciplinary Center, Herzliya. Prof. Rotstein has acted as an expert consultant in the construction of several medical facilities throughout the world including Centro Medico La Paz, Equatorial Guinea (major referral hospital in Equatorial Guinea), the Lagoon Hospital, Accra, Ghana and currently the Hadassah Skolkovo, Moscow (a branch of Hadassah Medical Cluster Oncological Centre and Polyclinic of Skolkovo, Moscow Organization). During his extensive career, Prof. Rotstein served as treasurer at the State's Physician Organization, chairman of the World Fellowship of the Israel Medical Association (I.M.A.), and member of the Editorial Board of Associations des Médécins Israelites de France. Prof. Rotstein served as a committee member of the I.M.A. Scientific Committee. Most recently Prof. Rotstein served as Chairman of Israel's Drug Basket Committee for 2020, one of the most important positions in the Israeli health system. Prof Rotstein is also a board member in NETO-MELINDA, a public company in Tel Aviv Stock Exchange. Prof. Rotstein holds a Phan M.D. in Cardiology from the Sackler School of Medicine at the Tel- Aviv University, and an M.B.A. (cum laude) from the Leon Recanati Graduate School of Business Administration at the Tel- Aviv University, and has held fellowships at the New York Department of Health, Tufts University, and Johns Hopkins Medical Centre School of Hygiene and Public Health.
- Urs Wettstein
-
Urs Wettstein自2017年2月以来一直担任我们的董事会成员。此后，Wettstein先生一直担任众多首次公开募股前投资的顾问和投资者。从2001年到2014年，他曾担任LifeWatch AG（原名:Six:Life）的非执行Vice Chairman of the Board。从1983年到2007年，他管理和运营自己的会计、审计和税务咨询公司，该公司由他在瑞士苏黎世创立。Wettstein先生是一名瑞士注册会计师。
Urs Wettstein,has served on G Medical Innovations Holdings Ltd. board of directors since February 2017. Mr. Wettstein has been an advisor and investor in numerous pre-IPO investments since. From 2001 to 2014, he served as non-executive vice chairman of the board of directors of LifeWatch AG (previously, SIX: LIFE). From 1983 to 2007, he managed and operated his own accounting, auditing and tax consultancy firm that he founded in Zurich, Switzerland. Mr. Wettstein is a Swiss Certified Public Accountant. - Urs Wettstein自2017年2月以来一直担任我们的董事会成员。此后，Wettstein先生一直担任众多首次公开募股前投资的顾问和投资者。从2001年到2014年，他曾担任LifeWatch AG（原名:Six:Life）的非执行Vice Chairman of the Board。从1983年到2007年，他管理和运营自己的会计、审计和税务咨询公司，该公司由他在瑞士苏黎世创立。Wettstein先生是一名瑞士注册会计师。
- Urs Wettstein,has served on G Medical Innovations Holdings Ltd. board of directors since February 2017. Mr. Wettstein has been an advisor and investor in numerous pre-IPO investments since. From 2001 to 2014, he served as non-executive vice chairman of the board of directors of LifeWatch AG (previously, SIX: LIFE). From 1983 to 2007, he managed and operated his own accounting, auditing and tax consultancy firm that he founded in Zurich, Switzerland. Mr. Wettstein is a Swiss Certified Public Accountant.
- Yacov Geva
-
Yacov Geva医疗技术和远程病人监护服务行业的知名先驱。作为LifeWatch AG Former Card Guard AG和Card Guard Scientific Survival Ltd.的创始人，他成功带领公司进行首次公开募股。直到2014年，Geva博士是LifeWatch AG的成员，董事会主席兼公司首席执行官。1979年至1989年，Geva博士担任Vishay Israel（美国Vishay InterTechnology的子公司）的首席机械工程师。Geva博士拥有巴黎国际管理学院（International School of Management，Paris）机械与核工程理学学士学位、荣誉工商管理博士学位和牛津布鲁克斯大学（Oxford Brookes University）荣誉博士学位。Geva博士也是英国皇家医学学会（RSM）的高级成员。
Yacov Geva,has served as G Medical Innovations Holdings Ltd. President and Chief Executive Officer. A well-known pioneer in the industry of medical technologies and RPM services. As the founder of LifeWatch AG (former Card Guard AG and Card Guard Scientific Survival Ltd.) he successfully led the company to its initial public offering. From 1989 to 2014, Dr. Geva was a member and the Chairman of the Board of Directors and Corporate Chief Executive Officer of LifeWatch AG. During 1979 to 1989, Dr. Geva served as a Chief Mechanical Engineer with Vishay Israel - a subsidiary of Vishay Intertechnology, USA. Dr. Geva holds a B.Sc. in Mechanical and Nuclear Engineering from the Technion-Israeli Institute of Technology, a Ph.D. (with honors) in Business Administration from the International School of Management, Paris and an honorary doctorate from Oxford Brookes University. Dr. Geva is also a senior member of the royal society of medicine in the UK. - Yacov Geva医疗技术和远程病人监护服务行业的知名先驱。作为LifeWatch AG Former Card Guard AG和Card Guard Scientific Survival Ltd.的创始人，他成功带领公司进行首次公开募股。直到2014年，Geva博士是LifeWatch AG的成员，董事会主席兼公司首席执行官。1979年至1989年，Geva博士担任Vishay Israel（美国Vishay InterTechnology的子公司）的首席机械工程师。Geva博士拥有巴黎国际管理学院（International School of Management，Paris）机械与核工程理学学士学位、荣誉工商管理博士学位和牛津布鲁克斯大学（Oxford Brookes University）荣誉博士学位。Geva博士也是英国皇家医学学会（RSM）的高级成员。
- Yacov Geva,has served as G Medical Innovations Holdings Ltd. President and Chief Executive Officer. A well-known pioneer in the industry of medical technologies and RPM services. As the founder of LifeWatch AG (former Card Guard AG and Card Guard Scientific Survival Ltd.) he successfully led the company to its initial public offering. From 1989 to 2014, Dr. Geva was a member and the Chairman of the Board of Directors and Corporate Chief Executive Officer of LifeWatch AG. During 1979 to 1989, Dr. Geva served as a Chief Mechanical Engineer with Vishay Israel - a subsidiary of Vishay Intertechnology, USA. Dr. Geva holds a B.Sc. in Mechanical and Nuclear Engineering from the Technion-Israeli Institute of Technology, a Ph.D. (with honors) in Business Administration from the International School of Management, Paris and an honorary doctorate from Oxford Brookes University. Dr. Geva is also a senior member of the royal society of medicine in the UK.
- Chanan Epstein
-
Chanan Epstein已同意在本次发行完成后担任我们的董事会成员。Chanan Epstein是一名高级技术和电信高管，在国内外市场拥有丰富的经验。2000年以来，他一直担任Amdocs Nasdaq:DOX（电信和媒体公司的领先软件和服务供应商）的高级副总裁，并于1995年开始在Amdocs任职。在Amdocs，Epstein先生负责开发和维护全球主要客户关系。在此职位上，他还利用其首席执行官/CXO在北美和亚洲电信业的关系，在推动战略交易方面发挥了重要作用。在加入Amdocs之前，Epstein先生于1974年至1991年在以色列空军服役。他最终获得上校军衔，负责指挥、控制、通信和情报系统以及航空电子软件的研究与开发。在他的军事生涯中，Epstein先生在美国工作了几年，领导美国和以色列空军之间的关键战略合作，特别是领导通用动力公司的F-16航空电子软件项目。Epstein先生是许多私人和上市公司的董事会成员，包括MobileSmith Health（纳斯达克股票代码:MOS），RFCode和Copilot。他还是一位活跃的技术投资者，也是众多高管的导师。
Chanan Epstein,has served on G Medical Innovations Holdings Ltd. board of directors since June 2021. Since 2000, he has served as a Senior Vice President at Amdocs (Nasdaq: DOX), a leading software and service provider to telecom and media companies, and he began his service at Amdocs in 1995. At Amdocs, Mr. Epstein is responsible for developing and maintaining key customer relationships worldwide. Prior to joining Amdocs, from 1974 to 1991, Mr. Epstein served in the Israeli Air Force. Ultimately attaining the rank of Colonel, he oversaw research and development of Command, Control, Communications and Intelligence operational systems, as well as avionics software. During his military career, Mr. Epstein spent several years in the U.S. leading key strategic ventures between the U.S. and Israeli Air Forces, specifically heading up the F-16 avionics software project at General Dynamics. Mr. Epstein sits on the board of a number of private and public companies, including MobileSmith Health (Nasdaq: MOS), RFCode and Copilot. He is also an active technology investor and a mentor to numerous executives. Mr. Epstein received his BA in mathematics and computer science from Bar Ilan University in Israel, as well as participated (partially completed) in the master program of computer science at Weizmann institute in Israel. - Chanan Epstein已同意在本次发行完成后担任我们的董事会成员。Chanan Epstein是一名高级技术和电信高管，在国内外市场拥有丰富的经验。2000年以来，他一直担任Amdocs Nasdaq:DOX（电信和媒体公司的领先软件和服务供应商）的高级副总裁，并于1995年开始在Amdocs任职。在Amdocs，Epstein先生负责开发和维护全球主要客户关系。在此职位上，他还利用其首席执行官/CXO在北美和亚洲电信业的关系，在推动战略交易方面发挥了重要作用。在加入Amdocs之前，Epstein先生于1974年至1991年在以色列空军服役。他最终获得上校军衔，负责指挥、控制、通信和情报系统以及航空电子软件的研究与开发。在他的军事生涯中，Epstein先生在美国工作了几年，领导美国和以色列空军之间的关键战略合作，特别是领导通用动力公司的F-16航空电子软件项目。Epstein先生是许多私人和上市公司的董事会成员，包括MobileSmith Health（纳斯达克股票代码:MOS），RFCode和Copilot。他还是一位活跃的技术投资者，也是众多高管的导师。
- Chanan Epstein,has served on G Medical Innovations Holdings Ltd. board of directors since June 2021. Since 2000, he has served as a Senior Vice President at Amdocs (Nasdaq: DOX), a leading software and service provider to telecom and media companies, and he began his service at Amdocs in 1995. At Amdocs, Mr. Epstein is responsible for developing and maintaining key customer relationships worldwide. Prior to joining Amdocs, from 1974 to 1991, Mr. Epstein served in the Israeli Air Force. Ultimately attaining the rank of Colonel, he oversaw research and development of Command, Control, Communications and Intelligence operational systems, as well as avionics software. During his military career, Mr. Epstein spent several years in the U.S. leading key strategic ventures between the U.S. and Israeli Air Forces, specifically heading up the F-16 avionics software project at General Dynamics. Mr. Epstein sits on the board of a number of private and public companies, including MobileSmith Health (Nasdaq: MOS), RFCode and Copilot. He is also an active technology investor and a mentor to numerous executives. Mr. Epstein received his BA in mathematics and computer science from Bar Ilan University in Israel, as well as participated (partially completed) in the master program of computer science at Weizmann institute in Israel.
- Yehoshua Gleitman
-
Yehoshua Gleitman是外部董事。自2001年起，他曾担任铂金VC（一家风险投资公司）的管理合伙人。他目前担任Capital Point有限公司的董事局主席，是Teuza—— 一个新时代技术创业有限公司的董事。2000年~2005年，他是SFKT有限公司的首席执行官和董事。1997年~1999年，他是Ampal—美国以色列公司的首席执行官。在此之前，他曾在以色列政府和以色列工业担任多个高级管理职位，包括担任以色列工业与贸易的董事兼首席科学家；美国—以色列产业研发基金会的董事长，美国—以色列科学技术委员会的联合主席，是AIMS有限公司的董事总经理，埃洛普电光实业有限公司的（埃洛普）海洋以及空中作战的副总裁和总经理，以色列防卫部激光科的负责人。他担任新加坡驻以色列的名誉总领事，是霍隆技术研究所以及伊扎克·拉宾中心建设协会的执行委员会主席。 他持有希伯来大学物理化学的学士学位、理科硕士学位、博士学位。 他担任审核委员会及财务报表审查委员会主席，并担任公司治理、提名委员会及薪酬董事委员会的成员。根据公司法，他是董事会认证的拥有财务及会计专业知识。
Yehoshua Gleitman,has served on G Medical Innovations Holdings Ltd. board of directors since February 2017. Dr. Gleitman has served as the chairman of the Guangzhou Israel Biotech Fund since 2016, chairman of the board of directors of Capital Point Group since 2006, a board member and chairman of the audit and financial committees of Elbit Systems (Nasdaq, TASE: ESLT) from 2010 to March 2020, chairman of the YoYa Group since 2014, senior advisor to the World Bank (national policy for innovation) since 2001 and senior strategy advisor to Serbia Innovation Fund since 2014 and chair of Georgia tech investment committee. Prior to holding those positions, from 1992 to 1997, Dr. Gleitman was the Chief Scientist and Director General of Israel's Ministry of Industry and Trade, where he managed all of the Israeli Government technological program and was responsible for allocating over $1.5 billion in grants in the framework of promoting research and development activities in the Israeli high-tech industry. Dr. Gleitman also served as the chief executive officer of Ampal Investment Group (Nasdaq: AMPL), in which he led a $330 million joint venture with Motorola Israel, founding Mirs Communications Ltd., Israel's fourth largest cellular operator. Dr Gleitman is the Honorary Consul General of Singapore in Israel (since 1999) and a member of the board of government of HUJ. Dr. Gleitman holds a Ph.D. (with distinction), M.Sc. (with distinction) and B.Sc. in Physical Chemistry, from the Hebrew University of Jerusalem. - Yehoshua Gleitman是外部董事。自2001年起，他曾担任铂金VC（一家风险投资公司）的管理合伙人。他目前担任Capital Point有限公司的董事局主席，是Teuza—— 一个新时代技术创业有限公司的董事。2000年~2005年，他是SFKT有限公司的首席执行官和董事。1997年~1999年，他是Ampal—美国以色列公司的首席执行官。在此之前，他曾在以色列政府和以色列工业担任多个高级管理职位，包括担任以色列工业与贸易的董事兼首席科学家；美国—以色列产业研发基金会的董事长，美国—以色列科学技术委员会的联合主席，是AIMS有限公司的董事总经理，埃洛普电光实业有限公司的（埃洛普）海洋以及空中作战的副总裁和总经理，以色列防卫部激光科的负责人。他担任新加坡驻以色列的名誉总领事，是霍隆技术研究所以及伊扎克·拉宾中心建设协会的执行委员会主席。 他持有希伯来大学物理化学的学士学位、理科硕士学位、博士学位。 他担任审核委员会及财务报表审查委员会主席，并担任公司治理、提名委员会及薪酬董事委员会的成员。根据公司法，他是董事会认证的拥有财务及会计专业知识。
- Yehoshua Gleitman,has served on G Medical Innovations Holdings Ltd. board of directors since February 2017. Dr. Gleitman has served as the chairman of the Guangzhou Israel Biotech Fund since 2016, chairman of the board of directors of Capital Point Group since 2006, a board member and chairman of the audit and financial committees of Elbit Systems (Nasdaq, TASE: ESLT) from 2010 to March 2020, chairman of the YoYa Group since 2014, senior advisor to the World Bank (national policy for innovation) since 2001 and senior strategy advisor to Serbia Innovation Fund since 2014 and chair of Georgia tech investment committee. Prior to holding those positions, from 1992 to 1997, Dr. Gleitman was the Chief Scientist and Director General of Israel's Ministry of Industry and Trade, where he managed all of the Israeli Government technological program and was responsible for allocating over $1.5 billion in grants in the framework of promoting research and development activities in the Israeli high-tech industry. Dr. Gleitman also served as the chief executive officer of Ampal Investment Group (Nasdaq: AMPL), in which he led a $330 million joint venture with Motorola Israel, founding Mirs Communications Ltd., Israel's fourth largest cellular operator. Dr Gleitman is the Honorary Consul General of Singapore in Israel (since 1999) and a member of the board of government of HUJ. Dr. Gleitman holds a Ph.D. (with distinction), M.Sc. (with distinction) and B.Sc. in Physical Chemistry, from the Hebrew University of Jerusalem.
高管简历
中英对照 | 中文 | 英文- Benny Tal
Benny Tal自2017年12月以来一直担任我们的高级副总裁研究与开发。2014年至2017年，Tal先生担任Spectronix Ltd.的研究与开发经理。在此之前，Tal从2000年到2014年在LifeWatch Services，Inc.担任多个电子工程和运营职位。Tal先生是一位经验丰富的研究与开发经理，曾在研究行业工作过。Tal先生持有B.SC.以色列Ben-Gurion University电子工程硕士学位和工商管理硕士学位。
Benny Tal,has served as G Medical Innovations Holdings Ltd. Senior Vice President Research and Development since December 2017 and G Medical Innovations Holdings Ltd. Chief Technology Officer since 2021. From 2014 to 2017, Mr. Tal was the research and development manager of Spectronix Ltd. Prior to that, from 2000 to 2014, Mr. Tal served in several electronics engineering and operations positions in LifeWatch Services, Inc. Mr. Tal holds a B.Sc. in electrical engineering and M.B.A from Ben-Gurion University, Israel.- Benny Tal自2017年12月以来一直担任我们的高级副总裁研究与开发。2014年至2017年，Tal先生担任Spectronix Ltd.的研究与开发经理。在此之前，Tal从2000年到2014年在LifeWatch Services，Inc.担任多个电子工程和运营职位。Tal先生是一位经验丰富的研究与开发经理，曾在研究行业工作过。Tal先生持有B.SC.以色列Ben-Gurion University电子工程硕士学位和工商管理硕士学位。
- Benny Tal,has served as G Medical Innovations Holdings Ltd. Senior Vice President Research and Development since December 2017 and G Medical Innovations Holdings Ltd. Chief Technology Officer since 2021. From 2014 to 2017, Mr. Tal was the research and development manager of Spectronix Ltd. Prior to that, from 2000 to 2014, Mr. Tal served in several electronics engineering and operations positions in LifeWatch Services, Inc. Mr. Tal holds a B.Sc. in electrical engineering and M.B.A from Ben-Gurion University, Israel.
- Oded Shahar
Oded Shahar自2017年7月以来一直担任我们的高级副总裁并购。Shahar从2004年8月到2007年11月担任CR&233；dit Agricole Corporate and Investment Bank以色列分部主管。Shahar自2007年起管理自己的律师事务所，专门从事银行和国际投资、并购和国际合同。Shahar先生拥有法学学士学位。从特拉维夫大学（Tel Aviv University）获得公证人资格，是以色列律师协会（Israel Bar Association）的成员。
Oded Shahar,has served as G Medical Innovations Holdings Ltd. Senior Vice President Mergers and Acquisitions since July 2017.He held senior executive positions including head of the Israeli branch of Crédit Agricole Corporate and Investment Bank following hands-on experience in investment banking in Paris and private banking in Switzerland. From 2004 to 2007, Mr. Shahar was the Senior Country Officer in Israel of one of the top ten global banks. From 2007 to 2017, Mr. Shahar was the Senior Partner in one of Israel's leading law firms. Mr. Shahar is qualified as a lawyer and as a Notary and is a member of the Israel Bar Association. His fields of expertise are banking and international investments, mergers & acquisitions and international contracts.- Oded Shahar自2017年7月以来一直担任我们的高级副总裁并购。Shahar从2004年8月到2007年11月担任CR&233；dit Agricole Corporate and Investment Bank以色列分部主管。Shahar自2007年起管理自己的律师事务所，专门从事银行和国际投资、并购和国际合同。Shahar先生拥有法学学士学位。从特拉维夫大学（Tel Aviv University）获得公证人资格，是以色列律师协会（Israel Bar Association）的成员。
- Oded Shahar,has served as G Medical Innovations Holdings Ltd. Senior Vice President Mergers and Acquisitions since July 2017.He held senior executive positions including head of the Israeli branch of Crédit Agricole Corporate and Investment Bank following hands-on experience in investment banking in Paris and private banking in Switzerland. From 2004 to 2007, Mr. Shahar was the Senior Country Officer in Israel of one of the top ten global banks. From 2007 to 2017, Mr. Shahar was the Senior Partner in one of Israel's leading law firms. Mr. Shahar is qualified as a lawyer and as a Notary and is a member of the Israel Bar Association. His fields of expertise are banking and international investments, mergers & acquisitions and international contracts.
- Yacov Geva
Yacov Geva医疗技术和远程病人监护服务行业的知名先驱。作为LifeWatch AG Former Card Guard AG和Card Guard Scientific Survival Ltd.的创始人，他成功带领公司进行首次公开募股。直到2014年，Geva博士是LifeWatch AG的成员，董事会主席兼公司首席执行官。1979年至1989年，Geva博士担任Vishay Israel（美国Vishay InterTechnology的子公司）的首席机械工程师。Geva博士拥有巴黎国际管理学院（International School of Management，Paris）机械与核工程理学学士学位、荣誉工商管理博士学位和牛津布鲁克斯大学（Oxford Brookes University）荣誉博士学位。Geva博士也是英国皇家医学学会（RSM）的高级成员。
Yacov Geva,has served as G Medical Innovations Holdings Ltd. President and Chief Executive Officer. A well-known pioneer in the industry of medical technologies and RPM services. As the founder of LifeWatch AG (former Card Guard AG and Card Guard Scientific Survival Ltd.) he successfully led the company to its initial public offering. From 1989 to 2014, Dr. Geva was a member and the Chairman of the Board of Directors and Corporate Chief Executive Officer of LifeWatch AG. During 1979 to 1989, Dr. Geva served as a Chief Mechanical Engineer with Vishay Israel - a subsidiary of Vishay Intertechnology, USA. Dr. Geva holds a B.Sc. in Mechanical and Nuclear Engineering from the Technion-Israeli Institute of Technology, a Ph.D. (with honors) in Business Administration from the International School of Management, Paris and an honorary doctorate from Oxford Brookes University. Dr. Geva is also a senior member of the royal society of medicine in the UK.- Yacov Geva医疗技术和远程病人监护服务行业的知名先驱。作为LifeWatch AG Former Card Guard AG和Card Guard Scientific Survival Ltd.的创始人，他成功带领公司进行首次公开募股。直到2014年，Geva博士是LifeWatch AG的成员，董事会主席兼公司首席执行官。1979年至1989年，Geva博士担任Vishay Israel（美国Vishay InterTechnology的子公司）的首席机械工程师。Geva博士拥有巴黎国际管理学院（International School of Management，Paris）机械与核工程理学学士学位、荣誉工商管理博士学位和牛津布鲁克斯大学（Oxford Brookes University）荣誉博士学位。Geva博士也是英国皇家医学学会（RSM）的高级成员。
- Yacov Geva,has served as G Medical Innovations Holdings Ltd. President and Chief Executive Officer. A well-known pioneer in the industry of medical technologies and RPM services. As the founder of LifeWatch AG (former Card Guard AG and Card Guard Scientific Survival Ltd.) he successfully led the company to its initial public offering. From 1989 to 2014, Dr. Geva was a member and the Chairman of the Board of Directors and Corporate Chief Executive Officer of LifeWatch AG. During 1979 to 1989, Dr. Geva served as a Chief Mechanical Engineer with Vishay Israel - a subsidiary of Vishay Intertechnology, USA. Dr. Geva holds a B.Sc. in Mechanical and Nuclear Engineering from the Technion-Israeli Institute of Technology, a Ph.D. (with honors) in Business Administration from the International School of Management, Paris and an honorary doctorate from Oxford Brookes University. Dr. Geva is also a senior member of the royal society of medicine in the UK.
- Dror Nuriel Roth
Dror Nuriel Roth自2019年1月起担任美国运营执行副总裁。Nuriel-Roth女士专注于管理我们在孟菲斯，芝加哥和奥斯汀的设施中的所有运营方面，包括销售，临床，物流，报销，客户服务和管理式护理。Nuriel-Roth女士在医疗保健行业带来了多年的运营管理和项目管理经验。自2011年以来，Nuriel-Roth女士一直在LifeWatch Services Inc.担任各种职务，包括2016年11月至2017年11月担任运营高级副总裁，2014年5月至2016年11月担任业务运营副总裁，2011年6月至2014年5月担任报销总监。Nuriel-Roth女士拥有以色列赫策利亚跨学科中心的经济与金融工商管理学士学位和经济与营销工商管理硕士学位。
Dror Nuriel Roth,has served as the Executive Vice President of U.S. Operations since January 2019. Ms. Nuriel-Roth is focused on managing all operations aspects, including sales, clinical, logistics, reimbursements, customer service and managed care in G Medical Innovations Holdings Ltd. facilities in Memphis, Chicago and Austin.Since 2011, Ms. Nuriel-Roth has served in various capacities at LifeWatch Services Inc., including senior vice president of operations from November 2016 to November 2017, vice president of business operations from May 2014 to November 2016 and director of reimbursement from June 2011 to May 2014. Ms. Nuriel-Roth holds a Bachelor of Business Administration in Economy and Financing and Master of Business Administration in Economy and Marketing from the Interdisciplinary Center in Hertzelia, Israel.- Dror Nuriel Roth自2019年1月起担任美国运营执行副总裁。Nuriel-Roth女士专注于管理我们在孟菲斯，芝加哥和奥斯汀的设施中的所有运营方面，包括销售，临床，物流，报销，客户服务和管理式护理。Nuriel-Roth女士在医疗保健行业带来了多年的运营管理和项目管理经验。自2011年以来，Nuriel-Roth女士一直在LifeWatch Services Inc.担任各种职务，包括2016年11月至2017年11月担任运营高级副总裁，2014年5月至2016年11月担任业务运营副总裁，2011年6月至2014年5月担任报销总监。Nuriel-Roth女士拥有以色列赫策利亚跨学科中心的经济与金融工商管理学士学位和经济与营销工商管理硕士学位。
- Dror Nuriel Roth,has served as the Executive Vice President of U.S. Operations since January 2019. Ms. Nuriel-Roth is focused on managing all operations aspects, including sales, clinical, logistics, reimbursements, customer service and managed care in G Medical Innovations Holdings Ltd. facilities in Memphis, Chicago and Austin.Since 2011, Ms. Nuriel-Roth has served in various capacities at LifeWatch Services Inc., including senior vice president of operations from November 2016 to November 2017, vice president of business operations from May 2014 to November 2016 and director of reimbursement from June 2011 to May 2014. Ms. Nuriel-Roth holds a Bachelor of Business Administration in Economy and Financing and Master of Business Administration in Economy and Marketing from the Interdisciplinary Center in Hertzelia, Israel.
- Igor Bluvstein
Igor Bluvstein，自2022年7月31日起担任G Medical Innovations Holdings Ltd.首席财务官。布卢夫斯坦先生在电子商务、生物技术、石化和医用大麻行业的财务领导职位上有超过15年的工作经验。从2020年到2022年，布卢夫斯坦先生担任MDD Group of Companies的首席财务官和董事。2016年至2020年，他在Frutarom Industries Ltd.（被国际香料香精公司（纽约证券交易所代码：IFF）收购）担任区域首席财务官。2015年至2016年，他担任一家电子商务零售商的首席财务官。从2011年到2015年，布鲁夫斯坦先生担任Mirland Development Corporation PLC的财务总监。2008年至2011年，他在安永全球有限公司担任高级审计师。Bluvstein先生拥有以色列开放大学会计学和经济学学士学位。他是注册会计师（CPA）。
Igor Bluvstein,has served as G Medical Innovations Holdings Ltd. Chief Financial Officer since July 31, 2022. Mr. Bluvstein has over fifteen years of experience working in financial leadership positions in the e-commerce, biotechnology, petrochemical, and medical cannabis industries. From 2020 through 2022, Mr. Bluvstein served as the Chief Financial Officer and Director at MDD Group of Companies. From 2016 to 2020, he served as Regional Chief Financial Officer at Frutarom Industries Ltd. (acquired by International Flavors & Fragrances Inc. (NYSE: IFF)). From 2015 until 2016, he served as the Chief Financial Officer of an e-commerce retailer. From 2011 until 2015, Mr. Bluvstein served as a Financial Controller at Mirland Development Corporation PLC. From 2008 through 2011, he served as a senior auditor at Ernst & Young Global Limited. Mr. Bluvstein holds a Bachelor of Arts in accounting and economics from the Open University in Israel. He is a Certified Public Accountant (CPA).- Igor Bluvstein，自2022年7月31日起担任G Medical Innovations Holdings Ltd.首席财务官。布卢夫斯坦先生在电子商务、生物技术、石化和医用大麻行业的财务领导职位上有超过15年的工作经验。从2020年到2022年，布卢夫斯坦先生担任MDD Group of Companies的首席财务官和董事。2016年至2020年，他在Frutarom Industries Ltd.（被国际香料香精公司（纽约证券交易所代码：IFF）收购）担任区域首席财务官。2015年至2016年，他担任一家电子商务零售商的首席财务官。从2011年到2015年，布鲁夫斯坦先生担任Mirland Development Corporation PLC的财务总监。2008年至2011年，他在安永全球有限公司担任高级审计师。Bluvstein先生拥有以色列开放大学会计学和经济学学士学位。他是注册会计师（CPA）。
- Igor Bluvstein,has served as G Medical Innovations Holdings Ltd. Chief Financial Officer since July 31, 2022. Mr. Bluvstein has over fifteen years of experience working in financial leadership positions in the e-commerce, biotechnology, petrochemical, and medical cannabis industries. From 2020 through 2022, Mr. Bluvstein served as the Chief Financial Officer and Director at MDD Group of Companies. From 2016 to 2020, he served as Regional Chief Financial Officer at Frutarom Industries Ltd. (acquired by International Flavors & Fragrances Inc. (NYSE: IFF)). From 2015 until 2016, he served as the Chief Financial Officer of an e-commerce retailer. From 2011 until 2015, Mr. Bluvstein served as a Financial Controller at Mirland Development Corporation PLC. From 2008 through 2011, he served as a senior auditor at Ernst & Young Global Limited. Mr. Bluvstein holds a Bachelor of Arts in accounting and economics from the Open University in Israel. He is a Certified Public Accountant (CPA).